Sanofi to buy immunology biotech Blueprint for US$9.1 billion
Sanofi will pay US$129 per share in cash for the US biotech, it said in a statement. That represents a 27 per cent premium to Blueprint's closing price on May 30.
The pharmaceutical firm has touted its ambition to become an immunology powerhouse, and earlier this year it clinched a pact to buy a promising antibody drug for up to US$1.9 billion. Blueprint brings a pipeline of experimental immunology treatments and one medicine already on sale for a rare condition known as systemic mastocytosis.
'Sanofi still retains a sizable capacity for further acquisitions,' said chief executive officer Paul Hudson.
Pharmaceutical companies have shied away from larger deals in recent years, with the biggest so far in 2025 being Johnson & Johnson's acquisition of Intra-Cellular Therapies for US$14.6 billion.
The transaction announced on Monday (Jun 2) is the largest for Sanofi since it bought Bioverativ, a spinoff from biotech giant Biogen, in 2018. It includes a contingent value right linked to the performance of one of Blueprint's experimental drugs.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
'We see synergies with Sanofi's existing rare-disease footprint, but expect investors to question valuation and confidence in the remaining internal R&D offering,' Sarita Kapila and analyst colleagues at Morgan Stanley wrote in a note.
Sanofi shares fell 1 per cent in Paris trading. The stock has dropped about 7.5 per cent so far this year, under-performing European rivals such as GSK and Novartis AG. Blueprint surged 26 per cent in trading before US exchanges opened.
Hudson shocked investors in 2023 when his research and development spending plan triggered a profit warning and led to a stock sell-off that wiped out around US$25 billion in market value. Since then, Sanofi has successfully separated its consumer-health division and has worked to prove that the drugmaker's research unit, led by former venture capital hotshot Houman Ashrafian, can continue to produce blockbusters.
Potential blockbuster
Blueprint markets the drug Ayvakit in the US – known as Ayvakyt in Europe – for systemic mastocytosis, where an abnormal buildup of immune cells can cause symptoms such as hives, abdominal pain, bone pain and anemia. The treatment is projected to bring in US$2 billion in annual revenue by 2030.
The company has a medicine called elenestinib in development for the same ailment and another in mid-stage trials called BLU-808 for mast-cell disorders, including chronic urticaria where patients have regular itchy and sometimes painful hives. Blueprint also has an 'established presence' among specialist doctors, according to Sanofi.
The acquisition marks the culmination of a successful pivot by Blueprint, which was founded in 2008 and listed in 2015 with a focus on cancer therapies. After the dissolution of a partnership with Roche Holding forced it to withdraw an approved cancer drug from certain markets, it dialled back its efforts in cancer and doubled down on immunology.
Blueprint shareholders will also receive one non-tradeable contingent value right, which will pay the holder US$2 and US$4 per right for future development and regulatory milestones for BLU-808, which has the potential to treat a range of diseases.
The transaction implies an equity value of US$9.1 billion. Including the potential CVR payments, the deal amounts to about US$9.5 billion on a fully diluted basis.
Sanofi expects to complete the acquisition in the third quarter and said the deal will not have a significant impact on its financial guidance for 2025. BLOOMBERG
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
11 minutes ago
- Straits Times
Trump hits Brazil with tariffs, sanctions but key sectors excluded
Sign up now: Get ST's newsletters delivered to your inbox SAO PAULO/BRASILIA - U.S. President Donald Trump on Wednesday slapped a 50% tariff on most Brazilian goods to fight what he has called a "witch hunt" against former President Jair Bolsonaro, but softened the blow by excluding sectors such as aircraft, energy and orange juice from heavier levies. Trump announced the tariffs, some of the steepest levied on any economy in the U.S. trade war, as his administration also unveiled sanctions on the Brazilian supreme court justice who has been overseeing Bolsonaro's trial on charges of plotting a coup. "Alexandre de Moraes has taken it upon himself to be judge and jury in an unlawful witch hunt against U.S. and Brazilian citizens and companies," Treasury Secretary Scott Bessent said in a statement. Bessent said Moraes "is responsible for an oppressive campaign of censorship, arbitrary detentions that violate human rights, and politicized prosecutions — including against former President Jair Bolsonaro." Last week, the Brazilian justice levied search warrants and restraining orders against Bolsonaro over allegations he courted Trump's interference in his criminal case, in which he is accused of plotting to stop President Luiz Inacio Lula da Silva from taking office in 2023. Trump's final tariff order and the sanctions followed weeks of sparring with Lula, who has likened the U.S. president, a close ideological ally of Bolsonaro's, to an unwanted "emperor." On Wednesday, Lula and his government closed ranks behind Moraes, calling the U.S. sanctions "unacceptable." Top stories Swipe. Select. Stay informed. Singapore SMRT's finances hit by 2024 EWL disruption; profit after tax for trains division dips 8% Asia US-Malaysia tariff deal set for Aug 1 after Trump-Anwar phone call Business Deepening S'pore-Latin America ties a matter of urgency amid global trade uncertainty: Alvin Tan Singapore Underground pipe leak likely reason for water supply issues during Toa Payoh fire: Town council Multimedia 60 years, 60 items: A National Day game challenge Life Milo tees, kaya toast pimple patches, crockery: Here are the SG60 merch to collect Singapore SingHealth nurses get $5.7m from Wee Foundation for education, skills development Singapore 'Switching careers just as I became a dad was risky, but I had to do it for my family' "The Brazilian government considers the use of political arguments to defend the trade measures announced by the U.S. government against Brazilian exports to be unjustifiable," it said in a statement. Lula added that Brazil was willing to negotiate trade with the U.S., but that it would not give up on the tools it had at hand to defend itself, hinting that retaliation was possible. Still, Trump's tariff order threatened that if Brazil were to retaliate, the U.S. would also up the ante. DIPLOMACY AT WORK Despite Trump's effort to use the tariffs to alter the trajectory of a pivotal criminal trial, the range of exemptions came as a relief for many in Brasilia, who since Trump announced the tariff earlier this month had been urging protections for major exporters caught in the crossfire. "We're not facing the worst-case scenario," Brazilian Treasury Secretary Rogerio Ceron told reporters. The new tariffs will go into effect on August 6, not on Friday as Trump announced originally. Trump's executive order formalizing a 50% tariff excluded dozens of key Brazilian exports to the United States, including civil aircraft, pig iron, precious metals, wood pulp, energy and fertilizers. Planemaker Embraer, whose chief executive has met with officials in Washington and U.S. clients in recent days to plead its case for relief, said an initial review indicated that a 10% tariff imposed by Trump in April remains in place, with the exclusion applying to the additional 40%. The exceptions are likely a response to concerns from U.S. companies, rather than a step back from Trump's efforts to influence Brazilian politics, said Rafael Favetti, a partner at political consultancy Fatto Inteligencia Politica in Brasilia. "This also shows that Brazilian diplomacy did its work correctly by working to raise awareness among U.S. companies," he said. Brazil's minister of foreign affairs, Mauro Vieira, said he met with U.S. Secretary of State Marco Rubio on Wednesday to express the nation's willingness to discuss tariffs after negotiations stalled in June, though he stressed Bolsonaro's legal troubles were not up for debate. It remains unclear what Brazilian authorities "are bringing to the negotiating table to, for instance, open the domestic market," Goldman Sachs said in a note to clients. IMPACT SMALLER THAN EXPECTED The effective tariff rate on Brazilian shipments to the U.S. should be around 30.8%, lower than previously expected due to the exemptions, according to Goldman. Oil shipments to the U.S., which had been suspended, are set to restart after being spared, lobby group IBP said. Meanwhile, mining lobby Ibram said the exemptions covered 75% of mining exports. However, it was still too soon to celebrate, said former Brazilian trade secretary Welber Barral, estimating that Brazil exports some 3,000 different products to the United States. "There will be an impact," Barral said. Trump's tariff exemptions did not shield two of Brazil's key exports to the U.S., beef and coffee. Meatpackers expect to log $1 billion in losses in the second half of the year on the new tariffs, lobby group Abiec, which represents beef producers including JBS and Marfrig, said. Coffee exporters will also continue to push for exemptions, they said in a statement. The government said it was readying measures to protect Brazil's businesses and workers. If Brazil were to retaliate against Trump's measures, that "would generate a larger negative impact" on activity and inflation, Goldman said. "The political inclination may be to retaliate, but exporters and business associations have been urging the Brazilian administration to engage, negotiate and de-escalate." REUTERS
Business Times
14 minutes ago
- Business Times
Grab reports Q2 2025 earnings of US$35 million on higher revenue and margins
[SINGAPORE] Superapp Grab reported Q2 2025 earnings of US$35 million, reversing from a loss of US$53 million in the same year-ago period. This was driven by operating profit and lower finance costs, and also partially offset by higher income tax expenses in Q2 2025. Revenue for the period grew 23 per cent to US$819 million from US$664 million the year prior. Operating profit also rose to US$7 million in Q2 2025 from a loss of US$56 million in Q2 2024. This was driven by higher revenue, improved margins, cost management and lower share-based compensation expenses. Adjusted earnings before interest, taxes, depreciation and amortisation (Ebitda) rose 69 per cent to US$109 million from US$64 million. This was driven by growth in on-demand gross merchandise value and revenue, and improving profitability on a segment adjusted Ebitda basis. Grab's guidance for revenue and adjusted Ebitda remains unchanged. The company is still guiding for revenue to be between US$3.3 billion and US$3.4 billion with a 19 to 22 per cent growth. Adjusted Ebitda is guided to be between US$460 million and US$480 million with a 47 to 53 per cent growth. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up The company expects second half of 2025 to have a substantially stronger performance than the first half. On-demand gross merchandise value grew 21 per cent to US$5.4 billion in Q2 2025 from US$.4 billion in Q2 2024. Monthly transacting users also grew 13 per cent to 46.2 million in Q2 2025 from 40.9 million in Q2 2024. Partner incentives also grew 16 per cent to US$307 million in Q2 20255 from US$266 million in Q2 2024. Revenue for the financial segment grew 41 per cent to US$84 million in Q2 2025 from US$64 million in Q2 2024, the highest growth by percentage across Grab's business segments. This was driven by increased contributions from lending across GrabFin and the digital banks. The loan portfolio rose 78 per cent to US$708 million in Q2 2025 from US$397 million in Q2 2024. The total loans disbursed in Q2 2025 grew 44 per cent to US$721 million. Grab is guiding the loan portfolio to be above US$1 billion by the end of the year. This will be driven by personal lending products from all three digital banks, the buy now pay later product at GrabFin and the recently acquired small and medium enterprise lending business from Validus. Customer deposits in GXS and GX Banks hit US$1.5 billion in Q2 2025, from US$730 million in Q2 2024 and from US$1.4 billion in Q1 2025. Anthony Tan, chief executive officer and co-founder, Grab said: 'We will continue to execute on our strategy to drive product- and tech-led innovations to enhance the affordability and reliability of our services, further deepen user engagement and retention, while attracting new users to the Grab ecosystem.' The macroeconomic environment is top of mind at Grab, with the company leaning into affordability with its Saver product offerings across delivery and mobility. Grab's investments into its product has solidified its resilience and brought more users in. 'We are confident our strategy of focusing on user and partners, with a very user and partner centric lens for product development, will continue to drive sustainable and profitable growth for the business,' said Tan. Shares of Grab closed down 0.4 per cent or US$0.02 to US$5.29 on Wednesday.
Straits Times
40 minutes ago
- Straits Times
Praise Trump and speak simply: How the South Korean team negotiated its trade deal
Sign up now: Get ST's newsletters delivered to your inbox FILE PHOTO: South Korean Finance Minister Koo Yun-cheol speaks ahead of his departure to Washington to meet U.S. Treasury Secretary Scott Bessent, at the Incheon International Airport in Incheon, South Korea, July 29, 2025. Yonhap via REUTERS/File Photo SEOUL - The South Korean ministers tasked with negotiating a last-ditch trade deal with U.S. President Donald Trump said that to prepare they role-played and solicited tips for engaging with the unpredictable leader. Among the advice they received? Call Trump a "great person" and speak as simply as possible, Industry Minister Kim Jung-kwan told reporters in Washington after the deal was announced on Wednesday. The stakes were particularly high for South Korea, a major export-driven economy, and Kim and other members of the delegation have only been on the job for a few weeks after President Lee Jae Myung won a snap election in June. Kim called Trump a "master of negotiations" and said each of the team, which included Finance Minister Koo Yun-cheol and Minister for Trade Yeo Han-koo, took turns role-playing as the U.S. president to prepare. "We tried to talk like President Trump, and President Trump's way of talking is very terse and straightforward," Kim said. "We prepared a lot of scenarios on our own on how to answer this or that question." Koo said the team only knew for sure they would be meeting Trump when they saw it on social media. The meeting itself went for about half an hour and the two sides went back and forth on the amount of the investment fund, which was eventually settled at $350 billion, Koo said. Top stories Swipe. Select. Stay informed. Singapore SMRT's finances hit by 2024 EWL disruption; profit after tax for trains division dips 8% Asia US-Malaysia tariff deal set for Aug 1 after Trump-Anwar phone call Business Deepening S'pore-Latin America ties a matter of urgency amid global trade uncertainty: Alvin Tan Singapore Underground pipe leak likely reason for water supply issues during Toa Payoh fire: Town council Multimedia 60 years, 60 items: A National Day game challenge Life Milo tees, kaya toast pimple patches, crockery: Here are the SG60 merch to collect Singapore Driver in 2024 Tampines crash that killed 2 set to plead guilty in October Singapore 'Switching careers just as I became a dad was risky, but I had to do it for my family' "We collected a lot of negotiation strategies used by our counterparts in advance and thought a lot about how to respond, so the negotiation was very smooth," he said. Yeo quoted Trump as saying his personal involvement is rare in dealing with officials who are not heads of state, and means "he respects South Korea very much and attaches great importance to South Korea." Earlier in the talks the U.S. had pressed South Korea to lift restrictions on imports derived from cattle older than 30 months, but Yeo helped defuse that by showing the Americans a photo of massive protests that occurred years ago over concerns about mad cow disease. "I think it helped them to understand the situation in Korea," Kim said. REUTERS
